These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 11290537)
1. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. Guedez L; McMarlin AJ; Kingma DW; Bennett TA; Stetler-Stevenson M; Stetler-Stevenson WG Am J Pathol; 2001 Apr; 158(4):1207-15. PubMed ID: 11290537 [TBL] [Abstract][Full Text] [Related]
2. A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma. Yan L; Moses MA Am J Pathol; 2001 Apr; 158(4):1185-90. PubMed ID: 11290534 [No Abstract] [Full Text] [Related]
3. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines. Perez-Chacon G; de Los Rios C; Zapata JM Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456 [TBL] [Abstract][Full Text] [Related]
4. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Wolf J; Pawlita M; Bullerdiek J; zur Hausen H Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373 [TBL] [Abstract][Full Text] [Related]
5. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice. Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726 [TBL] [Abstract][Full Text] [Related]
6. Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells. Tosato G; Sgadari C; Taga K; Jones KD; Pike SE; Rosenberg A; Sechler JM; Magrath IT; Love LA; Bhatia K Blood; 1994 Feb; 83(3):776-84. PubMed ID: 8298139 [TBL] [Abstract][Full Text] [Related]
7. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes. Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875 [TBL] [Abstract][Full Text] [Related]
8. Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude mice. Gurtsevitch VE; O'Conor GT; Lenoir GM Int J Cancer; 1988 Jan; 41(1):87-95. PubMed ID: 2826348 [TBL] [Abstract][Full Text] [Related]
9. Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells. Wolf J; Draube A; Bohlen H; Jox A; Mücke S; Pawlita M; Möller P; Diehl V Int J Cancer; 1995 Feb; 60(4):527-33. PubMed ID: 7829268 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and Burkitt's lymphoma. Magrath I; Jain V; Bhatia K Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792 [TBL] [Abstract][Full Text] [Related]
11. β-elemene against Burkitt's lymphoma via activation of PUMA mediated apoptotic pathway. Hu T; Gao Y Biomed Pharmacother; 2018 Oct; 106():1557-1562. PubMed ID: 30119230 [TBL] [Abstract][Full Text] [Related]
12. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. Guedez L; Stetler-Stevenson WG; Wolff L; Wang J; Fukushima P; Mansoor A; Stetler-Stevenson M J Clin Invest; 1998 Dec; 102(11):2002-10. PubMed ID: 9835626 [TBL] [Abstract][Full Text] [Related]
13. Heterotransplantation of human Burkitt's lymphoma cell lines in athymic nude mice: tumor-host relationships. McManaway ME; Marti GE; Tosato G; Liu AK; al-Nasser AA; Kiwanuka J; Magrath IT Pathobiology; 1993; 61(3-4):164-72. PubMed ID: 8216838 [TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Guedez L; Courtemanch L; Stetler-Stevenson M Blood; 1998 Aug; 92(4):1342-9. PubMed ID: 9694723 [TBL] [Abstract][Full Text] [Related]
15. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells. Maruo S; Nanbo A; Takada K J Virol; 2001 Oct; 75(20):9977-82. PubMed ID: 11559830 [TBL] [Abstract][Full Text] [Related]
16. Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectors. Mücke S; Draube A; Polack A; Pawlita M; Massoudi N; Staratschek-Jox A; Bohlen H; Bornkamm G; Diehl V; Wolf J Int J Cancer; 2000 May; 86(3):301-6. PubMed ID: 10760815 [TBL] [Abstract][Full Text] [Related]
17. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss. Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies. Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121 [TBL] [Abstract][Full Text] [Related]
20. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12. Angiolillo AL; Sgadari C; Tosato G Ann N Y Acad Sci; 1996 Oct; 795():158-67. PubMed ID: 8958926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]